Biovara Limited incorporated as a wholly owned subsidiary of Oxilio Limited

Oxilio is a pioneering pharmaceutical drug development company working to identify, repurpose and commercialise existing drugs to address unmet needs in cancer therapy – rapidly and cost effectively.